• 

  Bharat Biotech promised 5 lakh Covaxin doses in May, supplied 1.5 lakh: Delhi govt to HC

  India | June 05, 2021 7:27 IST

  Delhi government on Friday told the Delhi High Court that Bharat Biotech supplied only 1.5 lakh doses of COVID-19 vaccine 'Covaxin' in May against a promise of five lakh doses.

• 

  Data sharing going on with WHO to give recognition to Covaxin: Govt

  India | June 04, 2021 21:56 IST

  Data sharing is going on with WHO to give recognition to Bharat Biotech's Covaxin, the government said, noting that it wants to achieve this "milestone" as soon as possible.

• 

  Bharat Biotech will start manufacturing 10 crore vaccines per month by October: BJP President

  News | May 30, 2021 14:00 IST

  From 2 companies to now 13 companies have been permitted to produce COVID vaccines. Soon 19 companies will do the same. Bharat Biotech, who has been manufacturing 1.3 crore vaccines a month, will start manufacturing 10 crore vaccines per month by October: BJP President

• 

  Jeetega India | Vaccine production to increase manifold from July

  News | May 28, 2021 21:41 IST

  Both Serum Institute of India (SII) and Bharat Biotech would be ramping up production of Covid vaccines in India from July. SII is manufacturing Oxford-AstraZeneca vaccine called Covishield in India, while Bharat Biotech is producing Covaxin.

• 

  Covaxin manufacturing to vaccination takes 4 months, says Bharat Biotech

  India | May 28, 2021 18:54 IST

  Manufacturing to supply of COVID-19 vaccine Covaxin involves four months of lag time depending on technology and regulatory approvals, Bharat Biotech said on Friday.

• 

  Global supply of COVAX hit due to coronavirus crisis in India, USAID tells lawmakers

  World | May 28, 2021 8:14 IST

  There are many parts of the world where one shot has been dispensed to health workers or frontline workers and the second shot has not been forthcoming, USAID told lawmakers on Thursday.

• 

  ICMR to examine effectiveness of AstraZeneca's SII-produced Covishield and Bharat Biotech's Covaxin

  India | May 26, 2021 21:49 IST

  Around 4K people above the age of 45 yrs who have taken either one or both doses of any of these two vaccines will be reviewed, according to Dr Tarun Bhatnagar, senior scientist at ICMR's NIE in Chennai.

• 

  Bharat Biotech expects EUL from WHO for Covaxin in July- September

  India | May 25, 2021 23:20 IST

  Bharat Biotech on Tuesday said it expects approval for its COVID-19 vaccine Covaxin from the World Health Organisation for Emergency Use Listing (EUL) during July-September.

• 

  Bharat Biotech delivered Covaxin to 30 cities in 1 month; aims WHO approval

  India | May 25, 2021 18:43 IST

  Bharat Biotech is a Hyderabad-based biotechnology company. Its Covid-19 vaccine, Covaxin, is currently being used for inoculation in India.

• 

  Bharat Biotech submitted 90% of documentation to WHO for emergency use listing for Covaxin

  India | May 24, 2021 23:49 IST

  The issue of the WHO's authorisation for emergency use listing (EUL) for Covaxin was discussed at a meeting between the top brass of the BBIL and senior officials of the Ministry of Health, Department of Biotechnology and the Ministry of External Affairs.

• 

  Covaxin trials on children likely from next month

  India | May 23, 2021 20:14 IST

  Bharat Biotech may commence paediatric trials of its Covid-19 vaccine Covaxin from June, a senior company official said. The vaccine maker has already received permission to carry out trials on children aged 2-18 years.

Advertisement
• 

  Bharat Biotech ramps up Covaxin production, to now manufacture 1 billion doses per year

  India | May 20, 2021 21:46 IST

  Bharat Biotech has said it plans to produce additional 200 million doses of COVID-19 vaccine at its subsidiary's Ankleshwar in Gujarat based facility, taking overall production volume of the vaccine to 1 billion (100 crore) dosages per annum.

• 

  More pharma firms should be allowed to make Covid vaccine: Gadkari

  India | May 19, 2021 12:31 IST

  There are two vaccine makers in the country currently -- Bharat Biotech and Serum Institute of India -- which are manufacturing Covaxin and Covishield, respectively. Only three vaccines have so far been approved to be sold in India --- Covaxin, Coveshield and Sputnik V.

• 

  Bharat Biotech's Karnataka facility to manufacture 5 crore Covaxin doses by August-end

  India | May 17, 2021 16:34 IST

  Bharat Biotech's Covaxin manufacturing facility is under construction in Kolar district of Karnataka.

• 

  Hester in talks with Bharat Biotech for production of Covaxin via technology transfer

  India | May 16, 2021 18:31 IST

  Hester Biosciences on Sunday said it has tied up with the Gujarat government to explore production of COVID-19 vaccine through technology transfer from Bharat Biotech. The Ahmedabad-based firm said it has already initiated the discussions with Bharat Biotech in this regard.

• 

  Gujarat govt in talks with Bharat Biotech to ramp up production of Covaxin: DBT

  India | May 15, 2021 23:50 IST

  To ramp up production of Covaxin, the Gujarat government, along with Hester Biosciences and OmniBRx, has firmed up its discussions with Bharat Biotech to produce 20 million doses per month, the Department of Biotechnology (DBT) said on Saturday.

• 

  Bharat Biotech setting up COVID vaccine unit in Karnataka: Deputy CM Ashwath Narayan

  India | May 14, 2021 20:15 IST

  The construction work has already begun and the govt has invited investors to make the vaccine in the State, he said.

• 

  Covaxin dispatched to various states like Gujarat, Assam: Bharat Biotech

  India | May 14, 2021 13:38 IST

  The Hyderabad-based vaccine major, which has come under fire from the Delhi government over supply-related issues, said it has also dispatched Covaxin lots to Kerala and Uttarakhand.

• 

  Bharat Biotech unit to make Pune plant functional by Aug-end

  India | May 14, 2021 9:49 IST

  Biovet Pvt Ltd, an associate firm of Bharat Biotech, is confident of making a plant at Manjari in Pune "fully functional" for vaccine production by August-end.

• 

  50 employees Bharat Biotech test COVID-19 positive; Joint MD's tweet draws bouquets and brickbats

  India | May 13, 2021 11:46 IST

  The Hyderabad-based firm is supplying Covaxin to 18 states, including Andhra Pradesh, Haryana, Odisha, Assam, Jammu & Kashmir, Tamil Nadu, Bihar, Jharkhand and Delhi.